180 related articles for article (PubMed ID: 35482980)
1. Prognostic role of SPRY4-IT1 in female breast carcinoma and malignant tumors of the reproductive system: A meta-analysis.
Qin X; Yin Q; Gao J; Shi X; Tang J; Hao L; Li P; Zhu J; Wang Y
Medicine (Baltimore); 2022 Apr; 101(16):e28969. PubMed ID: 35482980
[TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNA SPRY4-IT1 Can Predict Poor Prognosis in Digestive System Malignancies: a Meta-Analysis.
Sun C; Ding Y; Wang S; Hu W
Pathol Oncol Res; 2019 Jan; 25(1):89-95. PubMed ID: 28965279
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of the long non-coding RNA, SPRY4 Intronic Transcript 1, in patients with cancer: a meta-analysis.
Wang M; Dong X; Feng Y; Sun H; Shan N; Lu T
Oncotarget; 2017 May; 8(20):33713-33724. PubMed ID: 28410241
[TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA SPRY4-IT1 Can Predict Unfavorable Prognosis and Lymph Node Metastasis: a Meta-Analysis.
Li N; Tan Q; Jing W; Luo P; Tu J
Pathol Oncol Res; 2017 Oct; 23(4):731-736. PubMed ID: 28054316
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of the long non-coding RNA SPRY4-IT1 predicts poor prognosis in breast cancer.
Xiang Y; Chen Y; Shi Y; Wu X; Hao R; Li Q; Li D
Int J Clin Exp Pathol; 2019; 12(3):1003-1008. PubMed ID: 31933911
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer.
Peng W; Wu G; Fan H; Wu J; Feng J
Tumour Biol; 2015 Sep; 36(9):6751-8. PubMed ID: 25835973
[TBL] [Abstract][Full Text] [Related]
7. TUG1, SPRY4-IT1, and HULC as valuable prognostic biomarkers of survival in cancer: A PRISMA-compliant meta-analysis.
Zhong Y; Chen Z; Guo S; Liao X; Xie H; Zheng Y; Cai B; Huang P; Liu Y; Zhou Q; Liu Y; Huang W
Medicine (Baltimore); 2017 Nov; 96(46):e8583. PubMed ID: 29145271
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Long Noncoding RNA SPRY4-IT1 on Survival Outcomes in Human Carcinomas: A Systematic Review and Meta-Analysis with TCGA Database.
Wang HM; Li HJ; Chen JZ; Pei K; Zhang Q; Liu ZD; Qi YF
Biomed Res Int; 2020; 2020():5868602. PubMed ID: 33204703
[TBL] [Abstract][Full Text] [Related]
9. Up-Regulated Expression of SPRY4-IT1 Predicts Poor Prognosis in Colorectal Cancer.
Tan W; Song ZZ; Xu Q; Qu X; Li Z; Wang Y; Yu Q; Wang S
Med Sci Monit; 2017 Jan; 23():309-314. PubMed ID: 28099409
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of SPRY4-IT1 in efficacy and survival prediction in breast cancer patients undergoing neoadjuvant chemotherapy.
Zheng A; Zhang L; Song X; Jin F
Histol Histopathol; 2020 Apr; 35(4):361-370. PubMed ID: 31638266
[TBL] [Abstract][Full Text] [Related]
12. Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
Xie M; Nie FQ; Sun M; Xia R; Liu YW; Zhou P; De W; Liu XH
J Transl Med; 2015 Aug; 13():250. PubMed ID: 26238992
[TBL] [Abstract][Full Text] [Related]
13. The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression.
Shi Y; Li J; Liu Y; Ding J; Fan Y; Tian Y; Wang L; Lian Y; Wang K; Shu Y
Mol Cancer; 2015 Feb; 14():51. PubMed ID: 25742952
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA SPRY4-IT1 as a promising indicator for three field lymph-node dissection of thoracic esophageal carcinoma.
Qie P; Yin Q; Xun X; Song Y; Zhou S; Liu H; Feng J; Tian Z
J Cardiothorac Surg; 2021 Mar; 16(1):48. PubMed ID: 33757566
[TBL] [Abstract][Full Text] [Related]
15. PDK1-stabilized LncRNA SPRY4-IT1 promotes breast cancer progression via activating NF-κB signaling pathway.
Zhang Y; Chen H; Yuan R; Wang Y; Zhang D; Zeng Q; Jiang W; Zhang R; Chen T; Chai C; Guo B
Mol Carcinog; 2023 Jul; 62(7):1009-1024. PubMed ID: 37042573
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA SPRY4-IT1 is a prognostic factor for poor overall survival and has an oncogenic role in glioma.
Zhou Y; Wang DL; Pang Q
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3035-9. PubMed ID: 27460732
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA SPRY4-IT1 promotes proliferation and metastasis of hepatocellular carcinoma via mediating TNF signaling pathway.
Ma W; Chen X; Wu X; Li J; Mei C; Jing W; Teng L; Tu H; Jiang X; Wang G; Chen Y; Wang K; Wang H; Wei Y; Liu Z; Yuan Y
J Cell Physiol; 2020 Nov; 235(11):7849-7862. PubMed ID: 31943198
[TBL] [Abstract][Full Text] [Related]
19. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
[TBL] [Abstract][Full Text] [Related]
20. The N-terminal polypeptide derived from vMIP-II exerts its anti-tumor activity in human breast cancer by regulating lncRNA SPRY4-IT1.
Wu H; Wang Y; Chen T; Li Y; Wang H; Zhang L; Chen S; Wang W; Yang Q; Chen C
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30104400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
